BLUE - bluebird bio, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
3,597
3,597
3,662
250,734
44,674
Cost of revenue
10,077
10,077
38,857
5,396
2,978
Gross profit
-6,480
-6,480
-35,195
245,338
41,696
Operating expenses
Research development
240,764
240,764
319,946
587,956
582,413
Selling general and administrative
136,908
136,908
209,969
286,896
271,362
Total operating expenses
275,672
275,672
529,915
874,852
853,775
Operating income or loss
-282,152
-282,152
-565,110
-629,514
-812,079
Total other income/expenses net
14,659
14,659
1,851
-34
-12,835
Income before tax
-266,461
-266,461
-562,380
-618,009
-790,153
Income tax expense
117
117
258
686
-545
Income from continuing operations
-266,578
-266,578
-562,638
-618,695
-789,608
Net income
-266,578
-266,578
-819,378
-618,695
-789,608
Net income available to common shareholders
-266,578
-266,578
-819,378
-618,695
-789,608
Basic EPS
-
-3.39
-11.89
-9.95
-14.31
Diluted EPS
-
-3.39
-11.89
-9.95
-14.31
Basic average shares
-
78,585
68,910
62,178
55,191
Diluted average shares
-
78,585
68,910
62,178
55,191
EBITDA
-
-282,152
-565,110
-629,514
-812,079